moxonidine
Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => N-(4-Chloro-6-methoxy-2-methylpyrimidin-5-yl)-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)nitrous amide
[catalogue_number] => PA 13 0561002
[category_ids] => ,71,78,80,82,162,
[chemical_name] =>
[weight] => 299.68
[form] => C9H10ClN7O3
[cas] => NA
[pslug] => n-4-chloro-6-methoxy-2-methylpyrimidin-5-yl-n-1-nitroso-4-5-dihydro-1h-imidazol-2-yl-nitrous-amide-pa130561002
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
N-(4-Chloro-6-methoxy-2-methylpyrimidin-5-yl)-N-(1-nitroso-4,5-dihydro-1H-imidazol-2-yl)nitrous amide
Catalogue No.:PA 13 0561002
Molecular Formula : C9H10ClN7O3
Molecular Weight : 299.68
stdClass Object
(
[pname] => N-Nitroso-Moxonidine (mononitroso)
[catalogue_number] => PA 13 0561003
[category_ids] => ,84,162,
[chemical_name] =>
[weight] => 272.69
[form] => C9H13ClN6O2
[cas] => NA
[pslug] => n-nitroso-moxonidine-mononitroso-pa130561003
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
N-Nitroso-Moxonidine (mononitroso)
Catalogue No.:PA 13 0561003
Molecular Formula : C9H13ClN6O2
Molecular Weight : 272.69
